New study uses AI technology to understand cell dysfunction in ALS
Dr. Sai Zhang and colleagues will apply AI to an analysis of the different types of central nervous system cells affected by ALS.
Posted in
Artificial Intelligence
Ph.D. students to attend Simuvation March 16-19
Ph.D. students Raghuveer Chandrashekhar and Jordan Major have been selected to take part in 2024 SIMUVACTION on AI.
New University of Florida project uses AI to improve treatments for childhood muscular dystrophy
The project combines a massive dataset of sophisticated muscle imaging data with UF’s powerful artificial intelligence computing.
Aprinda Indahlastari’s art shines in annual scientific computation image contest
Her illustration was selected as one of the winning images in the annual Coalition for Academic Scientific Computation image contest.
Candice Adams-Mitchell awarded NIH fellowship designed to improve diversity in AI research
Adams-Mitchell hopes to advance scientific understanding of sickle cell disease.
PHHP Research Innovation Fund awards grants for AI and direct clinical impact projects
Dr. Hollea Ryan, Dr. Yiyang Liu and Dr. Rebecca Willcocks are among some of the first recipients of PHHP Research Innovation Fund awards.
Breast cancer pilots fund interdisciplinary, collaborative studies
Dr. Noah Hammarlund will create a polysocial risk score to improve adherence to guideline-based treatment for women with breast cancer.
Mastering the art of data: The power of a biostatistics degree in today’s job market
A degree in biostatistics from PHHP can prepare you for a career at the intersection of health and big data.
PHHP offers new funding program to help faculty reach their research goals
The PHHP Research Innovation Fund is designed to support pilot testing or feasibility studies that will place faculty members in an optimal position to obtain research funding from outside agencies.
Confronting AIDS in Florida with artificial intelligence
A UF research team is applying the power of artificial intelligence to medical records to uncover patterns of risk and bias that have left some Florida patients with poor access to today’s effective treatments.
